en

PRODUCT DETAIL

Nuvaxovid injekčná disperzia

Code 9350D
MA number EU/1/21/1618/001
Product Form: dis inj 10x5 ml (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Novavax CZ a.s., Czechia
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BN Covid-19 vaccines
J07BN04 Covid-19, protein subunit
Shelf life: 12
Container: glass vial
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.12.2021
Validity: 04.07.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.11.2023
eu-flag.png sk-flag.png